GEN Exclusives

More »

GEN News Highlights

Back to Item »

MAP Secures $60M Equity Financing as Migraine Drug Moves Closer to Regulatory Filing

Company plans confirmatory Phase III trial with Levadex during first quarter of 2010.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?